See more : Sinopec Kantons Holdings Limited (SNPKF) Income Statement Analysis – Financial Results
Complete financial analysis of Danaher Corporation (DHR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danaher Corporation, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- First Industrial Realty Trust, Inc. (FR) Income Statement Analysis – Financial Results
- Fundely Co., Ltd. (3137.T) Income Statement Analysis – Financial Results
- NexTone Inc. (7094.T) Income Statement Analysis – Financial Results
- Idsud S.A. (ALIDS.PA) Income Statement Analysis – Financial Results
- BHUDEVI INFRA PROJECTS LIMITED (BHUDEVI.BO) Income Statement Analysis – Financial Results
Danaher Corporation (DHR)
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.89B | 31.47B | 29.45B | 22.28B | 17.91B | 19.89B | 18.33B | 16.88B | 20.56B | 19.91B | 19.12B | 18.26B | 16.09B | 13.20B | 11.18B | 12.70B | 11.03B | 9.60B | 7.98B | 6.89B | 5.29B | 4.58B | 3.78B | 3.78B | 3.20B | 2.91B | 2.05B | 1.81B | 1.49B | 1.29B | 1.07B | 949.00M | 831.60M | 840.00M | 749.10M | 714.60M | 615.00M | 446.00M | 298.00M |
| Cost of Revenue | 9.86B | 12.52B | 11.50B | 9.81B | 7.93B | 8.79B | 8.14B | 7.55B | 9.80B | 9.47B | 9.16B | 8.85B | 7.91B | 6.58B | 5.90B | 6.76B | 5.99B | 5.35B | 4.54B | 4.00B | 3.15B | 2.79B | 2.34B | 2.17B | 1.83B | 1.71B | 1.31B | 1.17B | 981.10M | 889.70M | 753.00M | 670.30M | 601.90M | 573.30M | 499.10M | 462.00M | 406.40M | 342.40M | 239.70M |
| Gross Profit | 14.03B | 18.95B | 17.95B | 12.48B | 9.98B | 11.11B | 10.19B | 9.33B | 10.76B | 10.44B | 9.96B | 9.41B | 8.18B | 6.63B | 5.28B | 5.94B | 5.04B | 4.24B | 3.45B | 2.89B | 2.14B | 1.79B | 1.44B | 1.61B | 1.36B | 1.20B | 744.60M | 640.70M | 505.70M | 399.00M | 314.10M | 278.70M | 229.70M | 266.70M | 250.00M | 252.60M | 208.60M | 103.60M | 58.30M |
| Gross Profit Ratio | 58.74% | 60.21% | 60.95% | 55.98% | 55.74% | 55.83% | 55.61% | 55.29% | 52.34% | 52.44% | 52.08% | 51.56% | 50.82% | 50.19% | 47.21% | 46.78% | 45.72% | 44.22% | 43.15% | 41.99% | 40.41% | 39.02% | 38.19% | 42.66% | 42.62% | 41.15% | 36.30% | 35.36% | 34.01% | 30.96% | 29.43% | 29.37% | 27.62% | 31.75% | 33.37% | 35.35% | 33.92% | 23.23% | 19.56% |
| Research & Development | 1.50B | 1.75B | 1.74B | 1.35B | 1.13B | 1.23B | 1.13B | 975.10M | 1.24B | 1.31B | 1.25B | 1.14B | 1.02B | 809.48M | 632.65M | 725.44M | 601.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.25B | 8.52B | 8.20B | 6.90B | 5.59B | 6.47B | 6.04B | 5.61B | 6.05B | 5.70B | 5.43B | 5.18B | 4.61B | 3.67B | 3.19B | 3.35B | 2.71B | 2.74B | 2.18B | 1.80B | 1.32B | 1.09B | 872.68M | 909.90M | 778.40M | 722.10M | 401.60M | 345.90M | 266.90M | 208.50M | 180.20M | 180.60M | 161.60M | 165.50M | 136.90M | 130.40M | 110.60M | 61.30M | 31.60M |
| Other Expenses | 77.00M | -226.00M | 547.00M | 39.00M | 12.00M | 37.20M | 72.80M | 223.40M | 12.40M | 156.50M | 0.00 | 0.00 | 0.00 | 0.00 | -85.12M | 0.00 | -14.34M | -16.38M | 4.60M | -8.14M | -22.50M | 2.78B | 0.00 | 149.72M | 126.40M | 108.70M | 76.10M | 68.60M | 58.50M | 44.60M | 40.90M | 37.10M | 33.20M | 25.60M | 19.10M | 17.60M | 13.50M | 9.30M | 6.80M |
| Operating Expenses | 8.83B | 10.26B | 10.49B | 8.24B | 6.71B | 7.70B | 7.17B | 6.58B | 7.29B | 7.01B | 6.68B | 6.32B | 5.56B | 4.48B | 3.74B | 4.07B | 3.30B | 2.73B | 2.18B | 1.79B | 1.29B | 1.09B | 872.68M | 1.06B | 904.80M | 830.80M | 477.70M | 414.50M | 325.40M | 253.10M | 221.10M | 217.70M | 194.80M | 191.10M | 156.00M | 148.00M | 124.10M | 70.60M | 38.40M |
| Cost & Expenses | 18.69B | 22.78B | 21.99B | 18.05B | 14.64B | 16.49B | 15.31B | 14.13B | 17.09B | 16.48B | 15.84B | 15.17B | 13.47B | 11.06B | 9.64B | 10.83B | 9.29B | 8.08B | 6.72B | 5.78B | 4.45B | 3.88B | 3.21B | 3.23B | 2.74B | 2.54B | 1.78B | 1.59B | 1.31B | 1.14B | 974.10M | 888.00M | 796.70M | 764.40M | 655.10M | 610.00M | 530.50M | 413.00M | 278.10M |
| Interest Income | 303.00M | 41.00M | 11.00M | 71.00M | 139.00M | 9.20M | 7.50M | 200.00K | 5.30M | 16.70M | 5.70M | 3.20M | 5.15M | 6.07M | 5.03M | 10.00M | 6.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 286.00M | 211.00M | 238.00M | 275.00M | 108.60M | 157.40M | 162.70M | 184.40M | 162.80M | 122.70M | 145.90M | 157.50M | 141.64M | 120.78M | 122.66M | 130.17M | 109.70M | 0.00 | 0.00 | 0.00 | 0.00 | 43.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.17B | 2.13B | 2.17B | 1.78B | 1.19B | 1.18B | 1.24B | 1.13B | 1.05B | 938.50M | 895.00M | 839.80M | 634.93M | 397.08M | 341.59M | 339.29M | 268.49M | 217.19M | 176.97M | 156.13M | 133.44M | 129.57M | 178.39M | 149.72M | 126.40M | 108.70M | 76.10M | 68.60M | 58.50M | 44.60M | 40.90M | 37.10M | 33.20M | 25.60M | 19.10M | 17.60M | 13.50M | 9.30M | 6.80M |
| EBITDA | 7.50B | 9.71B | 10.01B | 6.59B | 4.60B | 4.28B | 4.34B | 4.03B | 3.21B | 4.54B | 4.61B | 4.01B | 3.22B | 2.86B | 1.89B | 2.22B | 2.02B | 1.74B | 1.46B | 1.26B | 979.43M | 824.41M | 750.13M | 701.87M | 584.40M | 498.70M | 343.00M | 294.80M | 238.80M | 190.50M | 133.90M | 98.10M | 68.10M | 101.20M | 113.10M | 122.20M | 98.00M | 42.30M | 26.70M |
| EBITDA Ratio | 31.39% | 34.08% | 34.29% | 27.45% | 25.74% | 23.92% | 23.68% | 24.30% | 22.07% | 22.81% | 21.84% | 21.95% | 20.24% | 21.67% | 16.89% | 17.47% | 18.09% | 17.91% | 18.11% | 18.19% | 18.08% | 17.87% | 21.68% | 18.58% | 18.65% | 17.74% | 16.72% | 16.27% | 16.06% | 14.78% | 11.76% | 9.65% | 7.49% | 11.42% | 14.12% | 16.95% | 15.63% | 7.69% | 6.68% |
| Operating Income | 5.20B | 8.69B | 7.47B | 4.23B | 3.27B | 3.40B | 3.02B | 2.75B | 3.47B | 3.43B | 3.27B | 3.17B | 2.62B | 2.17B | 1.54B | 1.87B | 1.74B | 1.52B | 1.26B | 1.11B | 846.00M | 701.12M | 502.01M | 552.15M | 458.00M | 366.80M | 266.90M | 226.20M | 180.30M | 145.90M | 93.00M | 61.00M | 34.90M | 75.60M | 94.00M | 104.60M | 84.50M | 33.00M | 19.90M |
| Operating Income Ratio | 21.77% | 27.61% | 25.35% | 18.99% | 18.25% | 17.11% | 16.48% | 16.29% | 16.87% | 17.23% | 17.13% | 17.33% | 16.27% | 16.41% | 13.79% | 14.72% | 15.79% | 15.82% | 15.84% | 16.04% | 15.98% | 15.32% | 13.27% | 14.62% | 14.33% | 12.60% | 13.01% | 12.48% | 12.13% | 11.32% | 8.72% | 6.43% | 4.20% | 9.00% | 12.55% | 14.64% | 13.74% | 7.40% | 6.68% |
| Total Other Income/Expenses | -158.00M | -390.00M | 133.00M | 264.00M | 35.90M | 237.80M | -82.40M | -123.90M | -122.80M | 50.50M | 291.10M | -154.30M | -289.95M | 176.33M | -117.62M | -120.17M | -103.61M | -89.15M | -13.13M | -47.42M | -48.96M | -43.65M | -25.75M | -29.23M | -28.50M | -49.80M | -12.90M | -16.80M | -7.20M | -9.30M | -2.00M | -4.30M | -8.60M | -13.50M | -14.90M | -31.60M | -41.10M | -15.20M | -5.80M |
| Income Before Tax | 5.04B | 8.29B | 7.60B | 4.50B | 3.31B | 3.29B | 2.94B | 2.61B | 3.32B | 3.48B | 3.57B | 3.01B | 2.45B | 2.34B | 1.42B | 1.75B | 1.64B | 1.45B | 1.23B | 1.06B | 797.04M | 657.47M | 476.26M | 522.92M | 429.50M | 301.10M | 253.80M | 209.80M | 173.10M | 136.60M | 91.00M | 56.70M | 26.30M | 62.10M | 79.10M | 73.00M | 43.40M | 17.80M | 14.10M |
| Income Before Tax Ratio | 21.11% | 26.35% | 25.80% | 20.17% | 18.45% | 16.55% | 16.03% | 15.47% | 16.16% | 17.48% | 18.65% | 16.49% | 15.21% | 17.74% | 12.74% | 13.78% | 14.85% | 15.07% | 15.46% | 15.35% | 15.06% | 14.36% | 12.59% | 13.84% | 13.43% | 10.35% | 12.37% | 11.58% | 11.64% | 10.60% | 8.53% | 5.97% | 3.16% | 7.39% | 10.56% | 10.22% | 7.06% | 3.99% | 4.73% |
| Income Tax Expense | 823.00M | 1.08B | 1.25B | 849.00M | 873.00M | 641.90M | 469.00M | 457.90M | 725.30M | 883.40M | 871.00M | 711.50M | 512.56M | 549.71M | 273.15M | 431.68M | 423.10M | 324.14M | 336.64M | 311.72M | 260.20M | 223.33M | 178.60M | 198.71M | 167.90M | 118.20M | 99.00M | 81.80M | 67.30M | 54.90M | 37.30M | 25.10M | 13.00M | 26.40M | 32.00M | 33.00M | 22.90M | 9.10M | 8.50M |
| Net Income | 4.76B | 7.21B | 6.43B | 3.65B | 3.01B | 2.65B | 2.49B | 2.55B | 3.36B | 2.60B | 2.70B | 2.39B | 2.17B | 1.79B | 1.15B | 1.32B | 1.37B | 1.12B | 897.80M | 746.00M | 536.83M | 290.39M | 297.67M | 324.21M | 261.60M | 182.90M | 154.80M | 207.80M | 108.40M | 81.70M | 17.70M | 31.60M | 13.30M | 35.70M | 61.10M | 39.00M | 20.10M | 8.70M | 5.60M |
| Net Income Ratio | 19.94% | 22.91% | 21.84% | 16.36% | 16.80% | 13.33% | 13.60% | 15.13% | 16.33% | 13.05% | 14.10% | 13.10% | 13.50% | 13.58% | 10.30% | 10.38% | 12.42% | 11.69% | 11.24% | 10.83% | 10.14% | 6.34% | 7.87% | 8.58% | 8.18% | 6.29% | 7.55% | 11.47% | 7.29% | 6.34% | 1.66% | 3.33% | 1.60% | 4.25% | 8.16% | 5.46% | 3.27% | 1.95% | 1.88% |
| EPS | 6.44 | 9.80 | 8.77 | 4.97 | 3.48 | 3.78 | 3.58 | 3.69 | 4.81 | 3.70 | 3.87 | 3.45 | 3.21 | 2.74 | 1.80 | 2.07 | 2.20 | 1.82 | 1.46 | 1.21 | 0.88 | 0.48 | 0.52 | 0.57 | 0.46 | 0.34 | 0.33 | 0.44 | 0.23 | 0.09 | 0.04 | 0.07 | 0.03 | 0.09 | 0.16 | 0.10 | 0.06 | 0.03 | 0.02 |
| EPS Diluted | 6.38 | 9.64 | 8.61 | 4.89 | 3.43 | 3.73 | 3.53 | 3.65 | 4.74 | 3.63 | 3.80 | 3.36 | 3.11 | 2.64 | 1.73 | 1.98 | 2.10 | 1.74 | 1.38 | 1.15 | 0.84 | 0.47 | 0.50 | 0.56 | 0.45 | 0.33 | 0.32 | 0.43 | 0.23 | 0.09 | 0.04 | 0.07 | 0.03 | 0.09 | 0.16 | 0.10 | 0.05 | 0.03 | 0.02 |
| Weighted Avg Shares Out | 736.50M | 725.10M | 714.60M | 706.20M | 715.00M | 700.60M | 695.80M | 691.20M | 698.10M | 702.20M | 696.00M | 693.40M | 676.20M | 653.20M | 641.53M | 638.72M | 622.45M | 615.97M | 617.81M | 617.93M | 613.58M | 600.90M | 574.52M | 569.88M | 567.33M | 559.26M | 571.52M | 532.27M | 471.30M | 933.23M | 442.50M | 451.43M | 443.33M | 420.00M | 376.00M | 380.49M | 365.45M | 316.36M | 320.00M |
| Weighted Avg Shares Out (Dil) | 743.10M | 737.10M | 736.80M | 718.70M | 725.50M | 710.20M | 706.10M | 699.80M | 708.50M | 716.10M | 711.00M | 713.10M | 701.20M | 683.30M | 671.48M | 671.73M | 658.92M | 650.50M | 655.97M | 655.40M | 646.28M | 633.93M | 607.39M | 582.00M | 584.36M | 575.95M | 589.38M | 544.65M | 476.48M | 933.23M | 442.50M | 451.43M | 443.33M | 420.00M | 376.00M | 390.00M | 382.86M | 348.00M | 320.00M |
Danaher Releases 2024 Sustainability Report
WASHINGTON , July 16, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Report which conveys the depth and scope of Danaher's sustainability program and highlights...
Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening
Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and microscopy expected to lead to better understanding of tumor structures and treatment strategies.
Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu The New DxC 500i Analyzer Incorporates Recently Introduced DxC 500 AU Chemistry Analyzer Technology with...
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.
Danaher Schedules Second Quarter 2024 Earnings Conference Call
WASHINGTON , June 24, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2024 on Tuesday, July 23, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour.
Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics
WASHINGTON , June 19, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President, Diagnostics effective as...
Global Flow Cytometry Industry Outlook Report, 2024-2032: Market Dynamics, Technology Insights, Patent Analysis (2014-2024), and Profiles of Leading Players Including BD and Danaher
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Global Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Immunology, Stem Cell, Apoptosis), Clinical (Cancer)) - Forecast to 2032" report has...
Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
Strength in the Life Sciences segment augurs well for Danaher (DHR). The company's measures to reward its shareholders are promising.
Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer
Move reflects increasing investment in AI as driving force for innovation and productivity. Company will host Innovation Summit in December focused on AI in R&D.
Why Is Danaher (DHR) Up 6.7% Since Last Earnings Report?
Danaher (DHR) reported earnings 30 days ago. What's next for the stock?
Source: https://incomestatements.info
Category: Stock Reports